Clinical Trial Update: Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating afatinib for advanced cutaneous squamous cell carcinoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING